Bile acids suppress the secretion of very-low-density lipoprotein by human hepatocytes in primary culture

Hepatology

Volumn 23, Issue 2, 1996, Pages 218-228

  Lin, Yuguang ^a   Havinga, Rick ^a   Verkade, Henkjan J ^a   Moshage, Han ^a   Slooff, Maarten J H ^a   Vonk, Roel J ^a   Kuipers, Folkert ^a,b  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; APOLIPOPROTEIN B; BILE ACID; CHOLESTEROL ESTER; LACTATE DEHYDROGENASE; LIPID; PHOSPHOLIPID; PROTEIN; TAUROCHOLIC ACID; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ARTICLE; ELECTRON MICROSCOPY; ENTEROHEPATIC CIRCULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; LIVER CELL; LIVER CELL CULTURE; PRIORITY JOURNAL; SECRETION;

EID: 0030046526     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.1996.v23.pm0008591844     Document Type: Article

References (25)

1. Verkade HJ, Vonk RJ, Kuipers F. New insights in the mechanism of bile acid-induced biliary lipid secretion. HEPATOLOGY 1995;21:1174-1189.
2. Oude Elferink RPJ, Ottenhof R, van Wijland M, Smit JJM, Schinkel AH, Groen AK. Regulation of biliary lipid secretion by mdr2 P-glycoprotein in the mouse. J Clin Invest 1995;95:31-38.
3. Gibbons GF. Assembly and secretion of hepatic very-low-density lipoprotein. Biochem J 1990;268:1-13.
4. Yao Z, McLeod RS. Synthesis and secretion of hepatic apolipoprotein B-containing lipoproteins. Biochim Biophys Acta 1994;1212:152-166.
5. Smit MJ, Verkade HJ, Havinga R, Vonk RJ, Scherphof GL, In't Veld G, Kuipers F. Dietary fish oil potentiates bile acid-induced cholesterol secretion into bile in rats. J Lipid Res 1994;35:301-310.
6. Stone BG, Evans CD. Evidence for a common biliary and VLDL cholesterol precursor pool in rat liver. J Lipid Res 1992;33:1665-1675.
7. Marzolo MP, Amigo L, Nervi F. Hepatic production of very low density lipoprotein, catabolism of low density lipoprotein, biliary lipid secretion, and bile salt synthesis in rats fed a bean (Phaseolus vulgaris) diet. J Lipid Res 1993;34:807-814.
8. Grundy SM, Ahrens EH, Salen G. Interruption of the enterohepatic circulation of bile acids in man: comparative effects of cholestyramine and ileal exclusion on cholesterol metabolism. J Lab Clin Med 1971;78:94-121.
9. Beil U, Crouse JR, Einarsson K, Grundy SM. Effects of interruption of the enterohepatic circulation of bile acids on the transport of very low density lipoprotein triglycerides. Metabolism 1982;31:438-444.
10. Angelin B, Einarsson K, Hellstrom K, Leijd B. Effects of cholestyramine and chenodeoxycholic acid on the metabolism of endogenous triglyceride in hyperlipoproteinemia. J Lipid Res 1978;19:1017-1024.
11. Angelin B, Leijd B, Hulcrantz R, Einarsson K Increased turnover of very low density lipoprotein triglyceride during treatment with cholestyramine in familial hypercholesterolaemia. J Intern Med 1990;227:201-206.
12. Akerlund JE, Björkhem I, Angelin B, Liljeqvist L, Einarsson K. Apparent selective bile acid malabsorption as a consequence of ileal exclusion: effects on bile acid, cholesterol, and lipoprotein metabolism. Gut 1994;35:1116-1120.
13. Angelin B, Leijd B. Effects of cholic acid on the metabolism of endogenous plasma triglyceride and on biliary lipid composition in hyperlipoproteinemia. J Lipid Res 1980;21:1-9.
14. Miller NE, Nestel PJ. Triglyceride-lowering effect of chenodeoxycholic acid in patients with endogenous hypertriglyceridemia. Lancet 1974;2:929-931.
15. Tint GS, Ginsberg H, Salen G, Lee NA, Shefer S. Chenodeoxycholic acid normalizes elevated lipoprotein secretion and catabolism in cerebrotendinous xanthomatosis. J Lipid Res 1989;30:633-640.
16. Angelin B, Hershon KS, Brunzell JD. Bile acid metabolism in hereditary forms of hypertriglyceridemia: evidence for an increased synthesis rate in monogenic familial hypertriglyceridemia. Proc Natl Acad Sci U S A 1987;84:5434-5438.
17. Duane WC. Abnormal bile acid absorption in familial hypertriglyceridemia. J Lipid Res 1995;36:96-107.
18. Angelin B, Einarsson K. Bile acids and lipoprotein metabolism. Atheroscler Rev 1986;15:41-66.
19. Del Pozo R, Barth CA. Bile acids inhibit secretion of very low density lipoprotein by rat hepatocytes. Biol Chem Hoppe-Seyler 1987;368:887-893.
20. Marchegiano P, Carubbi F, Tiribelli C, Amarri S, Stebel M, Lunazzi GC, Levy D, et al. Transport of sulfobromophthalein and taurocholate in the HepG2 cell line in relation to the expression of membrane carrier proteins. Biochem Biophys Res Commun 1992;183:1203-1208.
21. Javitt NB. HepG2 cells as a resource for metabolic studies: lipoprotein, cholesterol, and bile acids. FASEB J 1990;4:161-168.
22. Dixon JL, Ginsberg HN. Regulation of hepatic secretion of apolipoprotein B-containing lipoproteins: information obtained from cultured liver cells. J Lipid Res 1993;34:167-179.
23. Moshage H, Yap SH. Primary cultures of human hepatocytes: an unique system for studies in toxicology, virology, parasitology and pathophysiology in man. J Hepatol 1992;15:404-413.
24. Kalayoglu M, Sollinger HW, Stratta RJ, D'Allessandro AM, Hoffman RM, Pirsch JD, Beizer FO. Extended preservation of the liver for clinical transplantation. Lancet 1988;1:617-619.
25. Sandker GW, Weert B, Olinga P, Wolters H, Slooff MJH, Meijer DKF, Groothuis GMM. Characterization of transport in isolated human hepatocytes: a study with the bile acid taurocholic acid, the uncharged ouabain and the organic cations vecuronium and rocuronium. Biochem Pharmacol 1994;47:2193-2200.